Abstract
The contribution of chitosan as a scaffold material is quite significant in the field of tissue engineering, which is a multidisciplinary field of research and technology development requiring the involvement of chemists, physicists, chemical engineers, biologists, cell-biologists etc. to regenerate injured or damaged tissue. The advantages of using chitosan as a three-dimensional scaffold for tissue engineering applications are due to its versatile physicochemical and biological properties. Further, owing to its easy processability, it can be molded into the desired shape and size. Therefore, it is no exaggeration to say that chitosan is a promising biomaterial for tissue engineering scaffolds. There is an enormous body of work already published in various journals on chitosan as a tissue engineering scaffold but, to our knowledge, this work has not yet been brought together in one chapter. We have used our best efforts to accumulate the research work already done on chitosan in a single place so that chitosan researchers can easily find information and can therefore escalate their research activities. This chapter highlights different methods for the fabrication of scaffolds, the suitability of chitosan as a good scaffolding material, and its application as a scaffold for tissue engineering of bone, cartilage, skin, liver, corneal, vascular, nerve, and cardiac tissue.
Graphical Abstract
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
1 Introduction
A look at the world population reveals that the most common chronic problem associated with man is loss of tissue and organ damage. This can be cured by organ transplantation using tissue engineering techniques. The main problem associated with organ transplantation is shortage of suitable donors. This circumstance demands the need of a suitable scaffold wherein autologous cells can be grown under optimum conditions in vitro and subsequently transplanted back into the human body. This will obviate the need to wait for a donor and, on the other hand, will also increase the patients’ comfort and compliance. The very fundamental of tissue engineering is the requirement for a scaffold material with specific characteristics that provides a temporary artificial matrix for cell seeding [1]. One of the most important characteristics of a scaffold material is that it should provide an ideal site for cell attachment and proliferation, leading to further tissue engineering. The extracellular matrix (ECM) not only provides the physical support for cells but also regulates their proliferation and differentiation. Therefore, scaffolds need to be developed for sustaining in vitro tissue reconstruction as well as for in vivo cell-mediated tissue regeneration. Repair of tissue defects can only be possible if the cells are supplied with such an ECM substitute [2]. A scaffold is a support, either natural or artificial, that maintains tissue contour. Substances that are frequently used for scaffold preparation are natural polymers, synthetic polymers, or ceramics with adsorbed proteins or immobilized functional groups [3]. Natural polymers have drawn the attention of various researchers because of their outstanding biocompatibility properties. Biodegradable materials have gained more attention because they have the advantage of allowing new tissue to take over their load-bearing or other functions without creating any potential chronic problems associated with the presence of biostable implants [4]. The paradigm of tissue engineering consists of seeding cells on a scaffold made of either a synthetic or natural polymer blend, maturing the tissue in vitro, and finally implanting the construct at the desired site in the patient as an artificial prosthesis [5, 6]. Overall, the strategy of tissue engineering [7] generally involves the following steps:
-
1.
Identify, isolate, and produce an appropriate cell source in sufficient amount
-
2.
Synthesize a scaffold with the desired shape and dimension, which will subsequently be used as a cell carrier
-
3.
Seed the cells uniformly onto or into the carrier and incubate for a predetermined time in a bioreactor
-
4.
Implant the cell-seeded carrier in a proper animal model. Depending on the site and the structure, vascularization may be necessary
2 Scaffolds
Tissue scaffolds are synthetic bioresorbable polymers that act as functional substitutes for missing or malfunctioning human tissues and organ. The primary role of a scaffold is to provide a temporary substrate to which the transplanted cells can adhere [8]. The most important factors to be considered with respect to nutrient supply to transplanted and regenerated cells are porosity, pore size and pore structure for porous scaffolds with a large surface-area-to volume ratio, and void volume. Optimization of these parameters is desirable for attachment, growth, maximal cell seeding, ECM production, and vascularization. Pores of the same diameter are preferable in scaffolds in order to yield high surface area per volume, provided the pore size is greater than the diameter of a cell in suspension [1, 2].
Thus, scaffolds provide physical support to cells, and pores provide space for remodeling of tissue structures. The major challenge associated with the development of scaffolds is the organization of cells and tissue in a three-dimensional (3D) configuration so that molecular signals are presented in an appropriate spatial and temporal fashion in a common manner that promotes the individual cells to grow and form the desired tissue structures [9, 10].
2.1 Factors Governing the Design of Scaffolds
During design of a scaffold for real-life applications, we must pay attention in choosing the scaffold material, body acceptability, mechanical properties, surface chemistry, and porosity. The porosity, morphology, and mechanical strength of scaffolds are governed by various factors. Some of the factors governing the designing of scaffolds are discussed below.
2.1.1 Materials
During design of scaffolds for tissue engineering applications, one must emphasize the selection of suitable materials. The materials should be biocompatible and biodegradable (i.e., they can be degraded into harmless products, leaving the desired living tissue). Some of the materials used for fabricating scaffolds include natural polymers, synthetic polymers, ceramics, metals, and hybrids of these materials [11]. Metals and ceramics are not a good choice for tissue engineering applications because they are not biodegradable (except for bioceramics such as α-tricalcium phosphate and β-tricalcium phosphate) and because their processability is very limited. For these reasons, natural polymers have gained increased attention because they are biodegradable and biocompatible. One of the major drawbacks exhibited by scaffolds made up of natural polymers is their poor mechanical properties. These problems associated with natural polymers can be circumvented by using synthetic resorbable polymers such as poly(α-hydroxy esters), polyanhydrides, polyorthoesters, and polyphosphazens. Polyglycolic acid (PGA), polylactic acid (PLA), polydioxanone, and copolymers thereof are the only FDA-approved synthetic and degradable polymers.
2.1.2 Porosity and Surface Area
Scaffolds should be highly porous and the pores should be interconnected to favor tissue integration and vascularization. Scaffolds should have appropriate surface chemistry to provide the necessary initial support for the attachment and proliferation of cells, and for the retention of their differentiated functions [12]. The porosity and pore size of the scaffold play crucial roles in the regeneration of a specific tissue. For instance, scaffolds with pore size less than 150 μm have been successfully used for regeneration of skin in burn patients [13]. Angiogenesis is a requirement for some scaffold application scenarios and can be unpleasantly affected by material porosity. Pore morphology can also affect scaffold degradation kinetics and the mechanical properties of the developing tissue [14]. The degree of interconnectivity has a greater influence on osteoconduction than does the actual pore size [15]. Highly porous materials facilitate the easy diffusion of nutrients to, and waste products from, the implant. Similarly, the larger the surface area of the scaffold, the more it favors cell attachment and growth [16].
2.1.3 Mechanical Properties and Processability
The scaffold should possess good mechanical strength so that it can be used for the reconstruction of hard, load-bearing tissues such as bone and cartilage. The biomaterial should be easily processed so that it can be easily fabricated into different shapes and sizes to meet the needs of the desired tissue reconstruction. The scaffold’s architecture plays a vital role in maintaining its dimensional stability [15]. The scaffolds should have sufficient structural integrity that matches the mechanical properties of native tissue [17]. The external shape of the scaffold is also extremely important from the clinical point of view because the final anatomical shape of a regenerated tissue is basically dependent on the shape of the associated scaffold [18]. The mechanical properties of scaffold in tissue-engineering applications are of great importance due to the necessity of the structural stability to withstand stress incurred during culturing in vitro and implanting in vivo. In addition, the mechanical properties can significantly affect the specific biological functions of cells within the engineered tissue [19].
2.2 Scaffold Fabrication Techniques
Scaffolds can be fabricated by using different types of methodologies such as fiber bonding, salt leaching, gas-induced foaming, phase separation, electrospinning, solid freeform fabrication, and molecular self assembly [15, 17]. Some of the fabrication techniques are discussed below.
2.2.1 Salt Leaching
Salt leaching is one of the simplest fabrication methods for producing scaffolds with controllable porosity and pore size using various biodegradable polymers. The process for the manufacture of solid polymer–porogen constructs consists of combination of a suitable porogen with a solution of polymer in an appropriate mold. The porogen is then leached out to form porous sponges [20]. The traditional methods generally employ a solid porogen within a 3D polymer matrix to create well-defined pore size, pore structure, and total scaffold porosity. Murphy et al. [21] has introduced a modified method for producing porous, biodegradable tissue engineering scaffolds with improved pore interconnectivity. They fabricated a 3D porous scaffold by using a copolymer of 85:15 poly(lactide-co-glycolide) (PLG) via a solvent casting and particulate leaching process. They partially fused the NaCl crystals via treatment in 95% humidity to create the interconnecting pores, prior to the formation of a 3D polymer scaffold. This technique allows scaffolds for tissue engineering to be formed with minimal laboratory equipment and polymer amounts. Several recent modifications to this method demonstrate the tremendous pace of improvement in the manufacture of scaffolds with precise chemical, physical, and biological properties.
2.2.2 Phase Separation
Phase separation is one of the most popular techniques for fabricating porous scaffolds for tissue engineering applications. In this process, phase separation is induced by decreasing the temperature of a polymer solution, which results into two different phases, one having a high polymer concentration (polymer-rich phase) and one having a low polymer concentration (polymer-lean phase). The solvent from the polymer-lean phase is later removed by extraction, evaporation, or sublimation to leave behind open pores. The polymer in the polymer-rich phase solidifies into the skeleton of the polymer foam. This separation can be categorized into two types on the basis of the crystallization temperature of the solvent in the polymer solution. One type is solid–liquid phase separation and the other is liquid–liquid phase separation. When the solvent crystallization temperature is higher than the liquid–liquid phase separation temperature, then it can be separated by lowering the temperature and the process is known as solid–liquid phase separation. This process consists of crystallization of solvent, and the polymer is expelled from the solvent crystallization front. However, when the solvent crystallization temperature is much lower than the phase separation temperature, a liquid–liquid phase separation takes place on decreasing the temperature of the polymer solution. Phase separation is relatively a simple technique for the fabrication of scaffolds having highly organized structures [22].
2.2.3 Solid Freeform Fabrication
Control over internal architecture and interconnectivity is a tough task for researchers. These days, the solid freeform technique (SFF) has attracted the attention of researchers. SFF is a collective term for a group of techniques that can rapidly produce highly complex 3D physical objects using data generated by computer-aided design (CAD) systems, computer-based medical imaging modalities, digitizers, and other data makers. The technique involves in the manufacture of objects in a layer-by-layer fashion from the 3D computer design of the object [23]. Some of the advantages [24] of using SFF technique are listed below:
-
In SFF scaffolds, the 3D interconnection of the scaffold can be maintained at a wide porosity level
-
Using computerized tomography (CT) or magnetic resonance image (MRI) as the data source, scaffolds can be made with an external geometry conforming to the patients’ anatomic structure, and thus the external geometry of the scaffolds can also be designed and customized to fulfill the need of the tissue engineer to construct scaffolds for specific tissues
-
Scaffolds with a distinct material and design domain can be fabricated by using SFF techniques
Finite element analysis (FEA) and CAD can be combined with manufacturing technologies such as SFF to allow virtual design, characterization, and production of scaffold that is optimized for tissue replacement. This makes it possible to design and manufacture very complex tissue scaffold structures with functional components that are difficult to fabricate.
2.2.4 Supercritical Fluid Drying
Recently, various types of supercritical fluid processing methods have been developed for the production of microparticles, foams, fibers, and aerogels [25–27]. Fabrication of scaffolds using supercritical fluid has been reported recently by several researchers [28–30]. The rapid expansion of supercritical solutions (RESS) and the gas anti-solvent technique (GAS) are widely used for the formation of microparticles and fibers. In RESS, a supercritical solution is rapidly expanded, which leads to a rapid decrease of the polymer solubility in the supercritical fluid (SCF) and, finally, to the formation of microparticles or nanoparticles with narrow size distribution. In GAS, a polymer solution is expanded into a SCF, which acts as an anti-solvent since it is not miscible with polymer but is miscible with the organic solvent. Because the solvent is miscible with the SCF, it expands, resulting in the reduction of solvent capacity to support polymer dissolution [25]. The author’s laboratory [29, 30] have prepared chitosan scaffolds using supercritical carbon dioxide (scCO2). In the first step, the hydrogels were prepared and treated with organic solvent(s) and then placed in the chamber of a supercritical fluid reactor to undergo solvent exchange. Thereafter, the temperature and pressure were raised. Thus, the continuous flow of scCO2 through the sample replaced all the organic solvent with CO2 to obtain a porous chitosan scaffold.
2.2.5 Hydrothermal Preparation
The use of a hydrothermal bomb for preparation of a metal organic framework is a well-known technique in inorganic chemistry [31]. However, the use of a hydrothermal bomb for the preparation of scaffold is very rare. The final mixture with the appropriate composition for scaffold preparation is sealed in a PTFE-lined acid digestion bomb and heated at 40°C for 8 h under autogeneous pressure. After that, the bomb is kept at room temperature to cool the product, which is then frozen at −20°C. Finally, the product is vacuum dried to obtain the desired scaffolds [32–34] (Dutta PK et al., unpublished results).
2.2.6 Electrospinning
Another important scaffold fabrication technique is that of electrospun nanofibers. Electrospun nanofibers could be used to mimic the nanofibrous structure of the ECM in native tissue [35–37]. Electrospinning involves the ejection of a charged polymer fluid onto an oppositely charged surface. This technique is used to create polymeric fibers with diameters in the nanometer range. In electrospinning, a charge is applied to a polymer solution or melt, which is ejected toward an oppositely charged target. The body of the polymer solution or melt becomes charged, and electrostatic repulsion counteracts the surface tension so the droplets become stretched. At a critical point, a stream of liquid erupts from the surface. This point of eruption is known as the “Taylor cone.” When the applied voltage is increased beyond a threshold value, the electric forces in the droplet overcome the opposing surface tension forces and a narrow charged jet is ejected from the tip of the Taylor cone [38]. The commonly used polymers for the electrospinning method of fabrication are the aliphatic polyesters [39]. Preparation of chitosan scaffolds by electrospinning has been mentioned by various researchers [37, 40–42]. Duan et al. [43] developed a nanofibrous composite membrane of poly(lactide-co-glycolic acid) (PLGA)–chitosan/poly(vinyl alcohol) (PVA) by simultaneous electrospinning of PLGA and chitosan/PVA from two different syringes and mixing on a rotating drum to prepare a nanofibrous composite membrane, which was then crosslinked with glutaraldehyde (GA). The obtained composite membrane was cytocompatible for fibroblastic cells.
3 Chitosan as a Scaffolding Material
Among the naturally derived polymers such as gelatin, collagens, glycosaminoglycan (GAG), starch, and alginate, chitosan, a partially deacetylated derivative of chitin, is chemically similar to GAG and has many desirable properties that make it a suitable candidate for use as a tissue engineering scaffold. Fabricating the hybrid scaffolds by combining natural polymers with synthetic polymers and ceramics is the best method, because the hybrid scaffolds possess both the mechanical strength of synthetic polymers and the biodegradability of natural polymers [15].
The principal derivative of chitin, chitosan, has gained more attention as a scaffold in tissue regeneration due to: (1) the possibility of large scale production and low cost; (2) its positively charged and reactive functional groups that enable it to form complexes with anionic polymers, including proteins that help to regulate cellular activity, [44]; and (3) its antibacterial properties [45]. Apart from this, chitosan is hemocompatible and non-immunogenic, and is degradable into non-toxic oligosaccharides inside the body due to the action of lysozymes. But, chitosan lacks the tensile strength required to match that of several natural tissues [46, 47]. It has been reported that chitosan-based biomaterials do not lead to any inflammatory or allergic reaction following implantation, injection, topical application, or ingestion in the human body [48]. Chitosan possesses wound-healing properties and favors both soft and hard tissue regeneration [49, 50]. By contrast, many synthetic polymers exhibit physicochemical and mechanical properties comparable to those of the biological tissues that they are required to substitute, but are not sufficiently bioactive [51]. Polyesters such as PLA, PLGA, and polycaprolactone (PCL) can be reproduced with specific molecular weights, block structures, degradable linkages, and crosslinking modes, and have excellent mechanical strength [52, 53]. Thus, the lack of mechanical strength of chitosan scaffolds can be resolved by incorporation of inorganic materials so that the hybrid material possesses improved mechanical and biological properties. Many inorganic materials such as calcium carbonate, calcium phosphate, and silica have been studied for the preparation of chitosan–inorganic composites [54].
3.1 Structural Analysis and Characterization of Chitosan
The structure of chitosan plays an important role if it is to serve as a scaffold material for application in tissue engineering. The biocompatibility of chitosan is attributed to its chemical properties. The polysaccharide unit of chitosan resembles the structure of GAGs, which are a major component of ECM of bone and cartilage and, hence, chitosan could be an attractive candidate for an ECM substitute [55]. The cationic nature of chitosan facilitates pH-dependent electrostatic interaction with anionic GAGs, proteoglycans, and other negatively charged molecules. This property is of particular interest in tissue engineering because it makes chitosan suitable in various shapes and sizes, i.e., porous scaffolds [14], planar membranes [56], and hydrogels [57], for specific interactions with growth factors, receptors, and adhesion proteins [58]. The cell adhesion, proliferation, and differentiation properties of chitosan are attributed to its hydrophilic nature, and its compact aggregated polymeric chains are helpful in providing stability to the scaffolds in terms of size and morphology during cell culture [59].
The physical and mechanical properties of chitosan can be ameliorated by using graft copolymerization and crosslinking. Chitosan forms aldimines and ketimines with aldehydes and ketones, respectively. Upon hydrogenation with simple aldehydes, chitosan produces N-alkyl chitosan [60]. The physicochemical and biological properties [61] as well as conformational structures [62] of chitosan are very effective for biomedical applications.
3.2 Role of Molecular Weight and Degree of Deacetylation
The molecular weight (Mw) and degree of deacetylation (DD) of chitosan play pivotal roles in dictating the biological properties of chitosan scaffolds. Notably, the DD itself influences many of the properties of chitosan, namely mechanical properties, biodegradability, immunological activity, wound-healing properties, and osteogenesis enhancement [63–71]. Chitosan scaffolds with higher DD showed higher cell proliferation, lower biodegradation rate, and higher mechanical strength. One of the studies in this direction was done by Hsu et al. [71]. They investigated the role of DD and Mw of chitosan in terms of hydrophilicity, degradation, mechanical properties, and biocompatibility by seeding fibroblastic cells and immortalized rat chondrocytes (IRC) on chitosan films of differing DD and Mw. They observed that in the chitosan films having similar Mw, the higher the DD of chitosan, the smaller was the elongation of chitosan films; with similar DD, a higher Mw led to higher tensile strength. The results of degradation studies showed that for chitosan with the higher average Mw, higher DD led to a higher degradation rate. However, the result for chitosan films with the lower average Mw was found to be opposite, i.e., higher DD led to slower degradation. The average Mw has also some significant effect on degradation rate. For chitosan films having similar DDs, higher average Mw led to the higher degradation rate. The acetyl group, –NHCOCH3 of chitosan plays an important role in deciding the degradation rate. Chitosan with lower DD have more –NHCOCH3 groups and might be more amorphous and degrade faster. The results showed that with the lower average Mw, lower DD led to higher degradation rate of chitosan films. They got the inference from their study that hydrophilicity and biocompatibility of chitosan films were affected by DD. However, the rate of degradation and the mechanical properties were found to be affected by Mw.
Another study in this direction was performed by Chatelet et al. [72]. They investigated the effect of DD on the biological properties of chitosan films by culturing keratinocytes and fibroblasts on chitosan films having different DDs. They found that DD has no significant effect on the in vitro cytocompatibility of chitosan films towards keratinocytes and fibroblasts. They demonstrated that the lower the DD of chitosan, the lower was the cell adhesion on the films, and found that keratinocyte proliferation increases when the DD of chitosan films increases. They concluded from their study that the DD plays a key role in cell adhesion and proliferation, but does not change the cytocompatibility of chitosan.
4 Application of Chitosan for Regeneration of Various Types of Tissue
Chitosan scaffolds may find application in regeneration of skin tissue, liver tissue, bone and cartilage tissue, cardiac tissue, corneal tissue, and vascular tissue to mention a few [73]. A brief account of its application in various branches of tissue engineering is described in this section.
4.1 Skin Tissue
Dermal wounds are very widespread in man. The skin damage can be caused by heat, chemicals, electricity, ultraviolet, nuclear energy, or disease. In the case of wounds that extend entirely through the dermis such as full-thickness burns or deep ulcers, as a result of many skin substitutes such as xenografts, allografts, and autografts have been employed for wound healing. However, the disadvantages of these approaches include the limited availability of skin grafts in severely burned patients and the problems of disease transmission and immune response [52, 53]. One of the good alternatives to skin grafts for curing skin damage is to develop a tissue-engineered skin equivalent. Polymeric tissue scaffolds made of PLGA, collagen, and chitosan are currently being employed for tissue reconstruction [74, 75]. An ideal scaffold for skin tissue engineering should possess the characteristics of excellent biocompatibility, suitable microstructure such as 100–200 μm mean pore size and porosity above 90%, controllable biodegradability, and suitable mechanical properties [76–78]. A brief account of work done by some researchers in the field of skin tissue engineering is given in Table 1.
There are complications in skin tissue engineering for cases of severe burn (third degree burns). Composite skin substitutes are applied to patients suffering from extensive burns, but slow cell ingrowths and insufficient vascularization has made it unreliable for curing the people suffering from third degree burns [81]. Consequently, some researchers are leaning towards the approach of tissue engineering, which utilizes both engineering and life science disciplines, to promote skin regeneration and to sustain and recover skin function [82].
In this direction, some good results-oriented data was reported by Liu et al. [81]. The work demonstrated the fabrication and effect of controlled-release of fibroblast growth factor (bFGF) from chitosan–gelatin microspheres (CGMSs) loaded with bFGF, where human fibroblasts were cultured on the chitosan–gelatin scaffold itself. The comparative study looked at cell morphology, cell proliferation, GAG synthesis, and gene expression with respect to loading of bFGF on the chitosan–gelatin scaffold. The DNA assay result indicated that the DNA content of human fibroblasts seeded on the scaffolds with and without bFGF-CGMS increased with culture time. The cell proliferation was 1.47 times higher over a period of 2 weeks on the scaffolds with bFGF-CGMS than on scaffolds without. GAG production was also higher on scaffolds with bFGF-CGMS than on the chitosan–gelatin scaffolds. Scanning electron microscopy (SEM) observations were also in accordance with the suitability of scaffolds containing bFGF for skin tissue engineering. They indicated that human fibroblasts attached and spread well on the scaffolds with bFGF-CGMS. Overall, the results indicated that chitosan–gelatin scaffolds with bFGF have a good potential as tissue engineering scaffolds to improve skin regeneration efficacy and to promote vascularization.
Very recently, Dhandayuthapani et al. [83] reported the development of novel chitosan–gelatin blend nanofiber systems for skin tissue engineering applications. In this study, they were able to electrospin defect-free chitosan, gelatin, and chitosan–gelatin blend nanofibers with smooth morphology and diameters of 120–200 nm, 100–150 nm, and 120–220 nm, respectively, by optimizing the process and solution parameters. Chitosan and gelatin formed completely miscible blends, as evidenced from differential scanning calorimetry (DSC) and Fourier transform infrared (FTIR) spectroscopy measurements. The tensile strength of the chitosan–gelatin blend nanofibers (37.91 ± 4.42 MPa) was significantly higher than that of the gelatin nanofibers (7.23 ± 1.15 MPa) (p < 0.05) and comparable with that of normal human skin.
4.2 Bone and Cartilage Tissue
Scaffold serves as a temporary skeleton inserted into the sites of defective or lost bone to support and stimulate bone tissue regeneration while it gradually degrades and is replaced by new bone tissue [84–87]. Both bioactive ceramics and polymers are used as scaffolding materials. Bioceramics have chemical compositions resembling bone and they also allow osteogenesis. The major drawback of using bioceramics as scaffolding material are its brittle nature and low degradation rates. However, the biodegradation rates and mechanical properties of biopolymers can be tailored to a certain extent for specific applications. Biopolymers are particularly amenable for implantation and can be easily fabricated into desired shapes [15, 88]. Chitosan is widely used as scaffolding for the regeneration of bone tissue because of its osteocompatible and osteoconductive properties, and can enhance bone formation both in vitro and in vivo [51]. The scaffolds should possess excellent mechanical properties. The work done in the field of bone tissue engineering is outlined in Table 2.
As far as chitosan is concerned for cartilage tissue engineering applications, the rate of biodegradation of the scaffold (used to organize cells in vitro) plays a crucial role. The presence of non-biodegradable articles in soft tissue often causes acute foreign body reactions elicited by the body’s immune system that can result in severe inflammation and soreness around the implant site. Many studies have reported that chitin and chitosan are biodegradable polymers and that they degrade in vivo mainly through their susceptibility to enzymatic hydrolysis mediated by lysozyme, which is ubiquitous in the human body. However, this action is dependent on factors such as pH, type of chitin or chitosan, and chitosan preparation method. The use of chitosan as scaffolding material for cartilage tissue has been reported by many researchers [2, 101, 102]. Composite chondroitin-6-sulfate/dermatan sulfate/chitosan scaffolds were reported to be used for articular cartilage regeneration [103]. A brief account of work done in cartilage tissue engineering is described in Table 3.
4.3 Liver Tissue
Liver is one of the most important and complex organs, serving several essential functions in the body. A biohybrid artificial liver using isolated hepatocytes and polymer scaffolds is expected to be an alternative method of treatment for liver failure because the shortage of suitable donors and costly surgical procedure has limited the use of liver transplantation. For this approach, various scaffolds have been used and it has been shown that the scaffolding material is crucial for control of cell adhesion, growth, and tissue reconstruction [107]. For the culture of anchorage-dependent cells such as hepatocytes, scaffolds require specific interaction with ECM components, growth factor, and the cell surface receptor to ensure cell survival, differentiation, and function [108]. This must be taken into account during the design and selection of polymeric materials for liver tissue-engineering. Calcium alginate sponge has been used for hepatocyte culture [109]. However, the alginate sponge is mechanically unstable due to ion exchange of Ca2+ with monovalent cations, and it lacks the cell-adhesive signals that are necessary to preserve long-term hepatocyte function and to suppress apoptosis. Application of chitosan scaffolds in liver tissue engineering is described in Table 4.
4.4 Cardiac Tissue
Myocardial infarction is one of the major public health concerns and the leading cause of death all over the world [118]. Human myocardium lacks the possibility of regeneration after myocardial infarction [119]. This results in a progressive loss of functional myocardium and a successive enlargement of the left ventricular cavity, thus impairing cardiac function [120]. The loss of viable myocardium is irreversible and, if extensive, could result in heart failure. The only available treatment of end-stage heart failure is heart transplantation. Shortage of donor hearts and immunological rejection of the transplanted tissue has limited transplantation to certain patients only. One good alternative for the treatment of heart failure is the replacement of damaged tissue with a tissue-engineered graft generated using cells and biodegradable scaffolds [121]. An ideal scaffold for cardiac tissue engineering should be (1) highly porous with large interconnected pores, (2) hydrophilic, (3) structurally stable, (4) degradable, and (5) elastic (to enable transmission of contractile forces) [122, 123]. The main focus of cardiac tissue engineering is on the development of 3D heart muscle that can be utilized to augment the function of failing myocardium. Table 5 gives glimpses of work done on cardiac tissue engineering applications.
4.5 Vascular Tissue
Vascular diseases, such as blood vessel damage, atherosclerosis, and aneurysms, remain an obstacle for clinicians because of limited donor sites and the immune response to allograft and xenograft. Tissue-engineered blood vessel is an optimal alternative for blood vessel substitution. Vascular transplantation has been commonly used for the treatment of vascular diseases. An ideal scaffold for vascular tissue engineering should use a biocompatible polymer with suitable degradation rate and biological qualities that interact favorably with blood and cells. A variety of biodegradable polymers, like poly(glycerol-sebacate), PLA or PLGA, as well as collagen and chitosan have been evaluated as scaffolds to support the regeneration of tissue-engineered vascular graft. More detail work in this direction is presented in Table 6.
4.6 Corneal Tissue
In the human body, the eye is the most delicate and remarkable organ. The cornea is the transparent part of the eye that covers the iris, pupil, and anterior chamber. It has five distinct anatomical layers. From anterior to posterior, the five layers are corneal epithelium, Bowman’s layer, corneal stroma, Descemet’s membrane, and corneal endothelium. Due to some hereditary diseases, infection, or injury, the cornea becomes opacified and results in loss of vision. According to the World Health Organization, over 10 million individuals are blinded from corneal scarring. Corneal transplantation is the best way to overcome this kind of defect. In the USA, more than 40,000 corneas are transplanted successfully each year. Most patients receiving a corneal transplant suffer from corneal scarring or decompensation due to keratoconus, bullous keratopathy, corneal scars from trauma, Fuchs endothelial dystrophy, and stromal corneal dystrophies such as lattice, granular, or macular dystrophy. In addition to these, in much of the developing world, religious and cultural factors, lack of general education, and the absence of eye banking facilities prevent widespread cadaveric donation for corneal transplantation, leading to the need for an alternative to cadaveric corneal transplantation. Thus, shortage of donor corneal tissue has drawn the attention of researchers towards keratoprosthesis for the treatment of corneal blindness. The ideal keratoprosthesis would be inert and not rejected by the patient’s immune system, inexpensive, and maintain long-term clarity. In addition, it would be quick to implant, easy to examine, and allow an excellent view of the retina [131]. Due to its good optical transmittance, chitosan is widely used in corneal tissue engineering scaffolds and corneal regeneration; its transparency is above 85% at 400 nm [132]. Some more details of work in this field are given in Table 7.
4.7 Nerve Tissue
The nervous system plays a vital role in maintaining body functions. Nervous tissue is composed of two main cell types: neurons, which transmit impulses, and the neuralgia, which assist propagation of nerve impulses as well as provide nutrients to the neurons. The nervous system is a complex, sophisticated system that regulates and coordinates the basic functions and activities of our body. Overall, it plays the role of headmaster in giving instructions to all parts of the body. Yet the nervous system is complex and is vulnerable to various disorders. Nervous system disorders cause many diseases such as Alzheimer’s disease, brain cancer and brain tumors, Meningitis, Parkinson’s disease etc. In recent years, researchers are devoting efforts to cure these diseases by regenerating nervous tissue. Some studies showed that chitosan promotes survival and neurite outgrowth of neural cells in vitro [137–141]. In most of the studies, a nerve guidance conduit is employed for peripheral nerve regeneration. In general, a suitable material for peripheral nerve regeneration should possess the following properties [142, 143]:
-
1.
It must be biocompatible
-
2.
It must allow diffusion transport of nutrients while preventing external cells from entering the conduit
-
3.
The material must be degraded slowly enough to maintain a stable support structure for the entire regeneration process, but it should not remain in the body much longer than needed to prevent later compression of the nerve
-
4.
The material must be able to support cell adhesion and cell spreading on its surface
Chitosans have these biological properties and can serve as the main materials for artificial nerve conduits. Neural stem cells (NSCs) have drawn the interest of researchers because of their potential for neural regeneration [144]. Recently, Scanga et al. [145] reported that chitosan had the greatest surface amine content and the lowest equilibrium water content, which probably contributed to the greater viability of neural precursor cells (NPCs or stem and progenitor cells) as observed over 3 weeks in culture. Plating intact NPC colonies revealed greater cell migration on chitosan relative to the other hydrogels. Importantly, long-term cultures on chitosan showed no significant difference in total cell counts over time, suggesting no net cell growth. Together, these findings reveal chitosan as a promising material for the delivery of adult NPC cell-based therapies. Table 8 focuses on the development of chitosan-based biomaterials for neural tissue regeneration and neural stem cell implantation.
4.8 Some Other Applications
Apart from the above use of chitosan as scaffolding material in tissue engineering, it also finds application in periodontal tissue engineering [154, 155] and disc tissue engineering [156]. The other uses of chitosan as scaffolding material may find applications in esophageal tissue, dental tissue and breast tissue for organ-specific tissue regeneration.
5 Conclusions
Among other natural polysaccharides, chitosan is a very promising and versatile biomaterial due to the ease with which this material can be manipulated to fit certain circumstances. This discovery has opened several avenues of thought concerning chitosan as a biopolymer for tissue engineering applications. The fundamental principles of tissue engineering are based on living cells, signal molecules, and scaffold. Tissue engineering involves repair of injured body parts and restores their functions by using laboratory-grown tissues, materials, and artificial implants. In this chapter, we have mainly concentrated on the selection of chitosan as scaffolding material and looked at different types of scaffold fabrication techniques as well as the factors governing the design of scaffolds for various tissue engineering applications. It is hoped that this article will act as a research guide for beginners on the use of chitosan as a scaffold for the regeneration of various types of tissues and organs. The description of methods for producing tissue engineering scaffolds may also be useful for practitioners to understand the physicochemical and biological properties of chitosan scaffolds in their real-life application.
References
Dutta J, Dutta PK, Rinki K et al (2008) Current research on chitin and chitosan for tissue engineering applications and future demands on bioproducts. In: Jayakumar R, Prabaharan M (eds) Current research and developments on chitin and chitosan in biomaterials science. Research Signpost, Trivandrum
Malafaya PB, Pedro AJ, Peterbauer A et al (2005) Chitosan particles agglomerated scaffolds for cartilage and osteochondral tissue engineering approaches with adipose tissue derived stem cells. J Mater Sci Mater Medicine 16:1077–1085
Glowacki J, Mizuno S (2008) Collagen scaffolds for tissue engineering. Biopolymers 89:338–344
Wang M, Chen LJ, Weng J et al (2001) Manufacture and evaluation of bioactive and biodegradable materials and scaffolds for tissue engineering. J Mater Sci Mater Med 12:855–860
Hoerstrup SP, Lu L, Lysaght MJ et al (2004) Tissue engineering. In: Ratner BD, Hoffman AS, Schoen FJ et al (eds) Biomaterial science. Elsevier Academic, San Diego
Langer R, Vacanti JP (1993) Tissue engineering. Science 260:920–926
Ehrenfreund-Kleinman T, Golenser J, Domb AJ (2006) Polysachharide scaffolds for tissue engineering. In: Ma PX, Elisseeff J (eds) Scaffolding in tissue engineering. CRC, Boca Raton
Jagur-Grodzinski J (2003) Biomedical applications of polymers. e-polymers 012
Thein-Han WW, Kitiyanant Y, Mishra RDK (2008) Chitosan as scaffold matrix for tissue engineering. Mater Sci Technol 24:1062–1075
Duarte ARC, Mano JF, Reis RL (2009) Perspectives on supercritical fluid technology for 3D tissue engineering scaffold applications. J Bioact Compat Polym 24:385–400
Whang K, Healy E, Elenz DR (1999) Engineering bone regeneration with bioabsorbable scaffolds with novel microarchitecture. Tissue Eng 5:35–51
Verma P, Verma V, Ray AR (2005) Chitin and chitosan: chitosan as tissue engineering scaffolds. In: Dutta PK (ed) Chitin and chitosan: opportunities and challenges. SSM International Publication, Midnapore, West Bengal
O'Brien FJ, Harley BA, Yannas IV et al (2004) Influence of freezing rate on pore structure in freeze-dried collagen-GAG scaffolds. Biomaterials 25:1077–1086
Rinki K, Dutta J, Dutta PK (2007) Chitosan based scaffolds for tissue engineering applications. Asian Chitin J 3:69–78
Yang S, Leong K-F, Du Z et al (2001) The design of scaffolds for use in tissue engineering Part I Traditional factors. Tissue Eng 7:679–689
Chang BS, Lee C-K, Hong K-S et al (2000) Osteoconduction at porous hydroxyapatite with various pore configurations. Biomaterials 21:1291–1298
Shor L, Guceri S, Wen X et al (2007) Fabrication of three-dimensional polycaprolactone/hydroxyapatite tissue scaffolds and osteoblast-scaffold interactions in vitro. Biomaterials 28:5291–5297
Wu L, Jing D, Ding JA (2006) “room-temperature” injection molding/particulate leaching approach for fabrication of biodegradable three-dimensional porous scaffolds. Biomaterials 27:185–191
Ingber D, Karp S, Plopper G et al (1993) Mechanochemical transduction across extracellular matrix and through the cytoskeleton. In: Frangos JA, Ives CL (eds) Physical forces and the mammalian cell. Academic, San Diego
Tessmar JKV, Holland TA, Mikos AG (2006) Salt leaching for polymer scaffolds: laboratory-scale manufacture of cell carriers. In: Ma PX, Elisseeff J (eds) Scaffolding in tissue engineering. CRC, Boca Raton
Murphy WL, Dennis RG, Kileny JL et al (2002) Salt fusion: an approach to improve pore interconnectivity within tissue engineering scaffolds. Tissue Eng 8:43–52
Wang AJ, Cao WL, Gong K et al (2006) Controlling morphology and porosity of 3-D chitosan scaffolds produced by thermally induced phase separation technique. Asian Chitin J 2:69–78
Leong KF, Cheah CM, Chua CK (2003) Solid freeform fabrication of three-dimensional scaffolds for engineering replacement tissues and organs. Biomaterials 24:2363–2378
Sahai N (2010) Characterization of porous tissue scaffolds using computer aided tissue engineering. M Tech dissertation submitted to MNNIT, Allahabad
Partap S, Hebb AK, Rehman I et al (2007) Formation of porous natural-synthetic polymer composites using emulsion templating and supercritical fluid assisted impregnation. Polym Bull 58:849–860
Hu X, Lessery AJ (2006) Solid-state processing of polymer in the presence of supercritical carbon Dioxide. J Cell Plast 42:517–527
Rinki K, Dutta PK, Hunt AJ et al (2011) Chitosan aerogel exhibiting high surface area for biomedical applications: preparation, characterization and antibacterial study. Int J Polym Mater Article ID 553849 (GPOM-2010–0362.R1)
Sachlos E, Wahl DA, Triffitt JT et al (2008) The impact of critical point drying with liquid carbon dioxide on collagen-hydroxyapatite composite scaffolds. Acta Biomater 4:1322–1331
Rinki K, Dutta PK (2008) Preparation of genipin crosslinked chitosan scaffolds using supercritical carbon dioxide (sc. CO2). Asian Chitin J 4:43–48
Rinki K, Dutta PK, Hunt AJ et al (2009) Preparation of chitosan scaffolds using supercritical carbon dioxide. Macromol Symp 277:36–42
Wei X, Wang K, Chen J (2011) The functional inorganic composites. Prog Chem 23:42–52
Rinki K, Shipra T, Dutta PK et al (2009) Direct chitosan scaffold formation via chitin whiskers by a supercritical carbon dioxide method: a green approach. J Mater Chem 19:8651–8655
Rinki K, Dutta PK (2010) Chitosan based scaffolds by lyophilization and sc. CO2 assisted methods for tissue engineering applications: a benign green chemistry approach. J Macromol Sci Pure Appl Chem A47:429–434
Rinki K, Dutta PK (2010) Physicochemical and biological activity study of genipin-crosslinked chitosan scaffolds prepared by using supercritical carbon dioxide for tissue engineering applications. Int J Biol Macromol 46:261–266
Jayakumar R, Prabaharan M, Nair SV et al (2010) Novel chitin and chitosan nanofibers in biomedical applications. Biotechnol Adv 28:142–150
Li W-J, Laurencin CT, Caterson EJ et al (2002) Electrospun nanofibrous structure: a novel scaffold for tissue engineering. J Biomed Mater Res 60:613–621
Mo X, Chen Z, Hans JW (2007) Electrospun nanofibers of collagen-chitosan and P(LLA-CL) for tissue engineering. Front Mater Sci China 1:20–23
Kharande TS, Agrawal CM (2008) Functions and requirements of synthetic scaffolds in tissue engineering. In: Laurencin CT, Nair LS (eds) Nanotechnology and tissue engineering: the scaffold. CRC, Boca Raton
Kang YM, Lee BN, Ko JH et al (2010) In vivo biocompatibility study of electrospun chitosan microfiber for tissue engineering. Int J Mol Sci 11:4140–4148
Pillai CKS, Chandra PS (2009) Electrospinning of chitin and chitosan nanofibres. Trends Biomater Artif Organs 22:175–197
Liang D, Hsiao BS, Chu B (2007) Functional electrospun nanofibrous scaffolds for biomedical applications. Adv Drug Deliv Rev 59:1392–1412
Jia Y-T, Gong J, Xiao-Hua Gu et al (2007) Fabrication and characterization of poly (vinyl alcohol)/chitosan blend nanofibers produced by electrospinning method. Carbohydr Polym 67:403–409
Duan B, Yuan X, Zhu Y et al (2006) A nanofibrous composite membrane of PLGA–chitosan/PVA prepared by electrospinning. Eur Polym J 42:2013–2022
Chupa JM, Foster AM, Sumner SR et al (2000) Vascular cell responses to polysaccharide materials: in vitro and in vivo evaluations. Biomaterials 21:2315–2322
Dutta PK, Tripathi S, Mehrotra GK et al (2009) Perspectives for chitosan based antimicrobial films for food applications. Food Chem 114:1173–1182
Dutta PK, Dutta J, Tripathi VS (2004) Chitin and chitosan: Chemistry, properties and applications. J Sci Ind Res 63:20–31
Dutta PK, Dutta J, Chattopadhyaya MC et al (2004) Chitin and chitosan: novel biomaterials waiting for future developments. J Polym Mater 21:321–334
Venkatesan J, Kim SK (2010) Chitosan composites for bone tissue engineering – an overview. Mar Drugs 8:2252–2266
Muzzarelli RAA (1993) Biochemical significance of exogenous chitins and chitosans in animals and patients. Carbohydr Polym 20:7–16
Archana D, Dutta J, Dutta PK (2010) Chitosan-pectin-titanium dioxide nano-composite film: an investigation for wound healing applications. Asian Chitin J 6:45–46
Seal BL, Otero TC, Panitch A (2001) Polymeric biomaterials for tissue and organ regeneration. Mater Sci Eng Res 34:147–230
Hasirci V, Lewandrowski K, Gresser JD et al (2001) Versatility of biodegradable biopolymers: degradability and an in vivo application. J Biotechnol 86:135–150
Marler JJ, Upton J, Langer R et al (1998) Transplantation of cells in matrices for tissue regeneration. Adv Drug Deliv Rev 33:165–182
Muzzarelli C, Muzzarelli RAA (2002) Natural and artificial chitosan-inorganic composites. J Inorg Biochem 92:89–94
Khor E, Lim LY (2003) Implantable applications of chitin and chitosan. Biomaterials 24:2339–2349
Mi FL, Shyu SS, Wu YB et al (2001) Fabrication and characterization of a sponge-like asymmetric chitosan membrane as a wound dressing. Biomaterials 22:165–173
Jayakumar R, Divyarani VV, Shalumon KT et al (2009) Development of novel α- and β-chitin hydrogel membranes for tissue engineering applications. Asian Chitin J 5:63–70
Jiang T, Nair LS, Laurencen CT (2006) Chitosan composites for tissue engineering: bone tissue engineering scaffolds. Asian Chitin J 2:1–10
Li J, Pan J, Zhang L, Yu Y (2003) Culture of hepatocytes on fructose-modified chitosan scaffolds. Biomaterials 24:2317–2322
Enescu D, Olteanu CE (2008) Functional chitosan and its use in pharmaceutical, biomedical, and biotechnological research. Chem Eng Commun 195:1269–1291
Wu T, Zivanovic S, Draughon FA et al (2005) Physicochemical properties and bioactivity of fungal chitin and chitosan. J Agric Food Chem 53:3888–3894
Dutta PK, Singh J (2008) Conformational study of chitosan: a review. Proceedings of the National Academy of Sciences India Part IV LXXVIII:255–270
Tomihata K, Ikada Y (1997) In vitro and in vivo degradation of films of chitin and its deacetylated derivatives. Biomaterials 18:567–575
Shigemasa Y, Saito K, Sashiwa H et al (1994) Enzymatic degradation of chitins and partially deacetylated chitins. Int J Biol Macromol 16:43–49
Hutadilok N, Mochimasu T, Hisamori H et al (1995) The effect of N-substitution on the hydrolysis of chitosan by an endo-chitosanase. Carbohydr Res 268:143–149
Nordtveit RJ, Varum KM, Smidsrod O (1996) The effect of N-substitution on the hydrolysis of chitosan by an endo-chitosanase. Carbohydr Polym 29:163–167
Varum KM, Myhr MM, Hjerde RJ et al (1997) In vitro degradation rates of partially N-acetylated chitosans in human serum. Carbohydr Res 299:99–101
Zhang K, Qian Y, Wang H et al (2010) Genipin-crosslinked silk fibroin/hydroxybutyl chitosan nanofibrous scaffolds for tissue-engineering application. J Biomed Mater Res 95A:870–881
Sathirakul K, How NC, Stevens WF et al (1996) Application of chitin and chitosan bandages for wound-healing. In: Domard A, Jeauniaux C, Muzzarelli R, Roberts G (eds) Proceedings of the first international conference of the European Chitin Society. Advances in chitin science, vol 1. Jacques Andre Publisher, Lyon
Hidaka Y, Ito M, Mori K et al (1999) Histopathological and immunohistochemical studies of membranes of deacetylated chitin derivatives implanted over rat calvaria. J Biomed Mater Res 46:418–423
Hsu S, Whu SW, Tsai C et al (2004) Chitosan as scaffold materials: effects of molecular weight and degree of deacetylation. J Polym Res 11:141–147
Chatelet C, Damour O, Domard A (2001) Infuence of the degree of acetylation on some biological properties of chitosan films. Biomaterials 22:261–268
Kim I-Y, Seo S-J, Moon H-S et al (2008) Chitosan and its derivatives for tissue engineering applications. Biotechnol Adv 26:1–21
Chen GP, Sato T, Ohgushi H et al (2005) Culturing of skin fibroblasts in a thin PLGA-collagen hybrid mesh. Biomaterials 26:2559–2566
Ma L, Gao CY, Mao ZW et al (2003) Collagen/chitosan porous scaffolds with improved biostability for skin tissue engineering. Biomaterials 24:4833–4841
Khnor E, Lim L (2003) Implantated applications of chitin and chitosan. Biomaterials 24:2339–2349
Ueno H, Mori T, Fujinaga T (2001) Topical formulations and wound healing applications of chitosan. Adv Drug Deliv Rev 52:105–115
Radhika M, Mary B, Sehgal PK (1999) Cellular proliferation on desamidated collagen matrices. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 124:131–139
Archana D, Dutta J, Dutta PK (2010) Synthesis, characterization and bioactivity with improved antibacterial effect of chitosan-pectin-titanium dioxide ternary film for biomedical applications. Asian Chitin J 6:26
Adekogbe I, Ghanem A (2005) Fabrication and characterization of DTBP-crosslinked chitosan scaffolds for skin tissue engineering. Biomaterials 26:7241–7250
Liu H, Fan H, Cui Y et al (2007) Effects of the controlled-released basic fibroblast growth factor from chitosan-gelatin microspheres on a chitosan-gelatin scaffold. Biomacromolecules 8:1446–1455
Powell HM, Boyce ST (2006) EDC cross-linking improves skin substitute strength and stability. Biomaterials 27:5821–5827
Dhandayuthapani B, Krishnan UM, Sethuraman S (2010) Fabrication and characterization of chitosan-gelatin blend nanofibers for skin tissue engineering. J Biomed Mater Res 94B:264–272
Lu G, Wang G, Sheng B et al (2008) Bimodal carboxymethyl chitosan/collagen nanofiber composite scaffolds for bone tissue engineering. Asian Chitin J 4:49–58
Service RF (2000) Tissue engineers build new bone. Science 289:1498–1500
Petite H, Viateau V, Bensaid W et al (2000) Tissue-engineered bone regeneration. Nat Biotechnol 18:959–963
Muzzarelli RAA (2009) Chitins and chitosans for the repair of wounded skin, nerve, cartilage and bone. Carbohydr Polym 76:167–182
Martins AM, Alves CM, Kasper FK et al (2010) Responsive and in situ-forming chitosan scaffolds for bone tissue engineering applications: an overview of the last decade. J Mater Chem 20:1638–1645
Li Z, Ramay HR, Hauch KD et al (2005) Chitosan–alginate hybrid scaffolds for bone tissue engineering. Biomaterials 26:3919–3928
Manjubala I, Ponomarev I, Jandt KD et al (2004) Adhesion and proliferation of osteoblastic cells seeded on chitosan-hydroxyapatite porous scaffold. Eur Cell Mater 7:64
Zhang Y, Ni M, Zhang M et al (2003) Calcium phosphate-chitosan composite scaffolds for bone tissue engineering. Tissue Eng 9:337–345
Jiang T, Abdel-Fattah WI, Laurencin CT (2006) In vitro evaluation of chitosan/poly(lactic acid-glycolic acid) sintered microsphere scaffolds for bone tissue engineering. Biomaterials 27:4894–4903
Xu HHK, Simon CG Jr (2005) Fast setting calcium phosphate-chitosan scaffold: mechanical properties and biocompatibility. Biomaterials 26:1337–1348
Kuo Y, Lin C (2006) Effect of genipin-crosslinked chitin-chitosan scaffolds with hydroxyapatite modifications on the cultivation of bovine knee chondrocytes. Biotechnol Bioeng 95:132–144
Yan LP, Wang YJ, Wu G et al (2010) Genipin-cross-linked collagen/chitosan biomimetic scaffolds for articular cartilage tissue engineering applications. J Biomed Mater Res 95A:465–475
Kong L, Gao Y, Lu G et al (2006) A study on the bioactivity of chitosan/nano-hydroxyapatite composite scaffolds for bone tissue engineering. Eur Polym J 42:3171–3179
Sailaja GS, Ramesh P, Kumary TV et al (2006) Human osteosarcoma cell adhesion behaviour on hydroxyapatite integrated chitosan–poly(acrylic acid) polyelectrolyte complex. Acta Biomater 2:651–657
Manjubala I, Ponomarev I, Wilke I et al (2008) Growth of osteoblast-like cells on biomimetic apatite-coated chitosan scaffolds. J Biomed Mater Res Appl Biomater 84B:7–16
Sendemir-Urkmez A, Jamison RD (2006) The addition of biphasic calcium phosphate to porous chitosan scaffolds enhances bone tissue development in vitro. J Biomed Mater Res 81A:624–633
Lee E, Shin D, Kim H et al (2009) Membrane of hybrid chitosan–silica xerogel for guided bone regeneration. Biomaterials 30:743–750
Lee JE, Jeong MH, Ahn HJ et al (2005) Evaluation of chondrogenesis in collagen/chitosan/glycosaminoglycan scaffolds for cartilage tissue engineering. Tissue Eng Regenerative Medicine 2:41–49
Yamane S, Iwasaki N, Majima T et al (2005) Feasibility of chitosan-based hyaluronic acid hybrid biomaterial for a novel scaffold in cartilage tissue engineering. Biomaterials 26:611–619
Chen YL, Lee HP, Chan HY et al (2007) Composite chondroitin-6-sulfate/dermatan sulphate/chitosan scaffolds for cartilage tissue engineering. Biomaterials 28:2294–2305
Wu H, Wan Y, Cao X et al (2008) Proliferation of chondrocytes on porous poly(DL-lactide)/chitosan scaffolds. Acta Biomater 4:76–87
Lao L, Tan H, Wang Y et al (2008) Chitosan modified poly(l-lactide) microspheres as cell microcarriers for cartilage tissue engineering. Colloids Surf B Biointerfaces 66:218–225
Tan H, Wu J, Lao L (2009) Gelatin/chitosan/hyaluronan scaffold integrated with PLGA microspheres for cartilage tissue engineering. Acta Biomater 5:328–337
Putnam AJ, Mooney DJ (1996) Tissue engineering using synthetic extracellular matrices. Nat Med 2:824–826
Smentana K (1993) Cell biology of hydrogels. Biomaterials 14:1046–1050
Cohen S, Glicklis R, Shapiro L et al (2000) Hepatocyte behavior within three-dimensional porous alginate scaffolds. Biotechnol Bioeng 67:344–353
Yang J, Chung TW, Nagaoka M et al (2001) Hepatocyte-specific porous polymer-scaffolds of alginate/galactosylated chitosan sponge for liver-tissue engineering. Biotechnol Lett 23:1385–1389
Chung TW, Yang J, Akaike T et al (2002) Preparation of alginate/galactosylated chitosan scaffold for hepatocyte attachment. Biomaterials 23:2827–2834
Seglen PO (1972) Preparation of rat liver cells. Exp Cell Res 74:450–454
Li J, Pan J, Zhang L et al (2003) Culture of hepatocytes on fructose-modified chitosan scaffolds. Biomaterials 24:2317–2322
Park IK, Yang J, Jeong HW et al (2003) Galactosylated chitosan as a synthetic extracellular matrix for hepatocytes attachment. Biomaterials 24:2331–2337
Wang XH, Li DP, Wang WJ et al (2003) Crosslinked collagen/chitosan matrix for artificial livers. Biomaterials 24:3213–3220
Jiankang H, Dichen L, Yaxiong L et al (2009) Preparation of chitosan–gelatin hybrid scaffolds with well-organized microstructures for hepatic tissue engineering. Acta Biomater 5:453–461
Feng ZQ, Chu X, Huang NP et al (2009) The effect of nanofibrous galactosylated chitosan scaffolds on the formation of rat primary hepatocyte aggregates and the maintenance of liver function. Biomaterials 30:2753–2763
Sivakumar R, Rajesh R, Buddhan S et al (2007) Antilipidemic effect of chitosan against experimentally induced myocardial infarction in rats. J Cell Animal Biol 1:71–77
Wei HJ, Chen CH, Lee WY et al (2008) Bioengineered cardiac patch constructed from multilayered mesenchymal stem cells for myocardial repair. Biomaterials 29:3547–3556
Perin EC, Dohmann HF, Borojevic R et al (2003) Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 107:2294–2302
Park H, Radisic M, Lim JO et al (2005) A novel composite scaffold for cardiac tissue engineering. In Vitro Cell Dev Biol – Animal 41:188–196
Freed LE, Vunjak-Novakovic G (2000) Tissue engineering bioreactors. In: Lanza RP, Langer R, Vacanti JP (eds) Principles of tissue engineering, 2nd edn. Academic, San Diego
Radisic M, Obradovic B, Vunjak-Novakovic G (2006) Functional tissue engineering of cartilage and myocardium: bioreactor aspects. In: Ma PX, Elisseeff J (eds) Scaffolding in tissue engineering. CRC, Boca Raton
Birla RK, Dow DE, Huang YC et al (2008) Methodology for the formation of functional, cell-based cardiac pressure generation constructs in vitro. In Vitro Cell Dev Biol – Animal 44:340–350
Blan NR, Birla RK (2008) Design and fabrication of heart muscle using scaffold-based tissue engineering. J Biomed Mater Res 86A:195–208
Cuy JL, Beckstead BL, Brown CD et al (2003) Adhesive protein interactions with chitosan: consequences for valve tissue-engineering. J Biomed Mater Res 67A:538–547
Liu L, Guo S, Chang J et al (2008) Surface Modification of polycaprolactone membrane via layer-by-layer deposition for promoting blood compatibility. J Biomed Mater Res Appl Biomater 87B:244–250
Zhu C, Fan D, Duan Z et al (2009) Initial investigation of novel human-like collagen/chitosan scaffold for vascular tissue engineering. J Biomed Mater Res 89A:829–840
Zhang L, Ao Q, Wang A et al (2006) A sandwich tubular scaffold derived from chitosan for blood vessel tissue engineering. J Biomed Mater Res 77A:277–284
He Q, Ao Q, Gong K et al (2010) Preparation and characterization of chitosan-heparin composite matrices for blood contacting tissue engineering. Biomed Mater 5:055001
Kalayoglu MV. In search of the artificial cornea: recent developments in keratoprostheses. http://www.medcompare.com/spotlight.asp?spotlightid=159
Wang Y, Guo L, Ren L et al (2009) A study on the performance of hyaluronic acid immobilized chitosan film. Biomed Mater 4:1–7
Gao X, Liu W, Han B et al (2008) Preparation and properties of a chitosan-based carrier of corneal endothelial cells. J Mater Sci Mater Med 19:3611–3619
Du LQ, Wu XY, Li MC et al (2008) Effect of different biomedical membranes on alkali-burned cornea. Ophthalmic Res 40:282–290
Chen J, Li Q, Xu J et al (2005) Study on biocompatibility of complexes of collagen–chitosan–sodium hyaluronate and cornea. Artif Organs 29:104–113
Rafat M, Li F, Fagerholm P et al (2008) PEG-stabilized carbodiimide crosslinked collagen–chitosan hydrogels for corneal tissue engineering. Biomaterials 29:3960–3972
Zielinski BA, Aebischer P (1991) Chitosan as a matrix for mammalian cell encapsulation. Biomaterials 15:1049–1056
Dillon GP, Yu X, Sridharan A et al (1998) The influence of physical structure and charge on neurite extension in a 3D hydrogel scaffold. J Biomater Sci Polym Edn 9:1049–1069
Dillon GP, Yu X, Bellamkonda RV (2000) The polarity and magnitude of ambient charge influences three-dimensional neurite extension from DRGs. J Biomed Mater Res 51A:510–519
Gong H, Zhong Y, Li J et al (2000) Studies on nerve cell affinity of chitosan-derived materials. J Biomed Mater Res 52A:285–295
Cheng M, Cao W, Gao Y et al (2003) Studies on nerve cell affinity of biodegradable modified chitosan films. J Biomater Sci Polym Edn 14:1155–1167
Midha R, Shoichet MS, Dalton PD et al (2001) Tissue engineered alternatives to nerve transplantation for repair of peripheral nervous system injuries. Transplant Proc 33:612
Keilhoff G, Stang F, Wolf G et al (2003) Bio-compatibility of type I/III collagen matrix for peripheral nerve reconstruction. Biomaterials 24:2779–2787
Ashtona RS, Banerjee A, Punyania S et al (2007) Scaffolds based on degradable alginate hydrogels and poly(lactide-co-glycolide) microspheres for stem cell culture. Biomaterials 28:5518–5525
Scanga VI, Goraltchouk A, Nussaiba N et al (2010) Biomaterials for neural-tissue engineering- chitosan supports the survival, migration, and differentiation of adult-derived neural stem and progenitor cells. Can J Chem 88:277–287
Frier T, Montenegro KHS et al (2005) Chitin-based tubes for tissue engineering in the nervous system. Biomaterials 26:4624–4632
Thein-Han WW, Kitiyanant Y (2007) Chitosan scaffolds for in vitro buffalo embryonic stem-like cell culture: an approach to tissue engineering. J Biomed Mater Res Appl Biomater 80B:92–101
Prabhakaran MP, Venugopal JR, Chyan TT et al (2008) Electrospun biocomposite nanofibrous scaffolds for neural tissue engineering. Tissue Eng 14:1787–1797
Wang AJ, Cao WL, Gong K et al (2006) Development of porous chitosan tubular scaffolds for tissue engineering applications. Asian Chitin J 2:53–60
Frier T, Koha HS, Kazaziana K et al (2005) Controlling cell adhesion and degradation of chitosan films by N-acetylation. Biomaterials 26:5872–5878
Xiangmei W, Jing Z, Hao C et al (2009) Preparation and characterization of collagen-based composite conduit for peripheral nerve regeneration. J Appl Polymer Sci 112:3652–3662
Ishikawa N, Suzuki Y, Dezawa M et al (2009) Peripheral nerve regeneration by transplantation of BMSC-derived Schwann cells. J Biomed mater Res 89A:1118–1124
Ishikawa N, Suzuki Y, Ohta M et al (2007) Peripheral nerve regeneration through the space formed by a chitosan gel sponge. J Biomed Mater Res 83A:33–40
Peng L, Cheng XR, Wang JW et al (2006) Preparation and evaluation of porous chitosan/collagen scaffolds for periodontal tissue engineering. J Bioactive Compatible Polym 21:207–220
Zhang Y, Song J, Shi B et al (2007) Combination of scaffold and adenovirus vectors expressing bone morphogenetic protein-7 for alveolar bone regeneration at dental implant defects. Biomaterials 28:4635–4642
Shao X, Hunter CJ (2007) Developing an alginate/chitosan hybrid fiber scaffold for annulus fibrous cells. J Biomed Mater Res 82A:701–710
Acknowledgments
Authors gratefully acknowledged the financial assistance to KR in the form of Institute Research Fellowship from MNNIT, Allahabad and research funding to PKD from UGC, New Delhi. The RSC (London) -Research Fund Grant Award-2009 to PKD is also gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Dutta, P.K., Rinki, K., Dutta, J. (2011). Chitosan: A Promising Biomaterial for Tissue Engineering Scaffolds. In: Jayakumar, R., Prabaharan, M., Muzzarelli, R. (eds) Chitosan for Biomaterials II. Advances in Polymer Science, vol 244. Springer, Berlin, Heidelberg. https://doi.org/10.1007/12_2011_112
Download citation
DOI: https://doi.org/10.1007/12_2011_112
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-24060-7
Online ISBN: 978-3-642-24061-4
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)